CLIA & Individualized Quality Control Plan (IQCP) Karen W. Dyer MT(ASCP), DLM Director (Acting) Division of Laboratory Services

Similar documents
CLIA & Individualized Quality Control Plan (IQCP) Judith Yost Director Division of Laboratory Services

5/8/2015. Individualized Quality Control Plans (IQCP) Changes to the CMS Quality Requirements. CLIA Quality Control Evolution of the Process

CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success

3/14/2016. The Joint Commission and IQCP. Objectives. Before Getting Started

CLIA S NEW IQCP SEABB. March 19, Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB

IQCP. Ensuring Your Laboratory s Compliance With Individualized Quality Control Plans. November/December 2016

IQCP January Is Coming Fast What Do I Do?!? Jean Ball Bold, MBA, MT(HHS), MLT(ASCP

Karen W. Dyer MT(ASCP), DLM Director, Division of Laboratory Services Centers for Medicare & Medicaid Services CLIA

US ): [42CFR ]:

CE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience

EDUCATIONAL COMMENTARY KEY COMPONENTS OF AN INDIVIDUALIZED QUALITY CONTROL PLAN

Center for Medicaid and State Operations/Survey and Certification Group

Centers for Medicare and Medicaid Services (CMS) Survey and Certification Group (SCG) Mission:

The CLIA regulations..

Learning Objectives. Individualized Quality Control Plans. Agenda. Another Way To Determine QC? Hooray!!!! What is QC?

Individualized Quality Control Plan (IQCP) Frequently Asked Questions Date: May 5, 2015 (last updated 08/21/2017)

CAP Most Frequent Deficiencies and How to Avoid Them. March 11, 2015

insights INTO Quality Control MAY/JUNE 2013 COLA S

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES

CAP Accreditation and Checklists Update. Lyn Wielgos, MT(ASCP) Checklist Editor, CAP Accreditation Programs

Page 17, APR.10 (new text for clarity)

Laboratory Risk Assessment: IQCP and Beyond. Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017

APPLICATION CHECKLIST

Trends in Nursing Facility Standard Health Survey Citations

CAP Forensic Drug Testing Accreditation Program Standards for Accreditation

ASSEMBLY BILL No. 940

4. Program Regulations

Policy Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail MISSION STATEMENT: OVERVIEW:

Page 3, Introduction (correcting a typo) Accreditation Participation Requirements (APR)

6/28/2016. Questions? Workshop 6 CAP Inspection Preparation Thursday, June 23, 2016

Laboratory Accreditation Manual Edition Editor: Francis E. Sharkey, MD, FCAP

Tutorial: Basic California State Laboratory Law

Improving Your POC Program: An Upside Down Map. Sheila K. Coffman MT(ASCP)

Standards for Forensic Drug Testing Accreditation

Scope of Service. Department Mission

Quality Assurance Program For Hospital Based Point of Care Testing. Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist

Clinical Laboratory Science Courses

SUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE

CLIA Regulations Update 2015

Internal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM

Medicare and Medicaid Program; Application from DNV GL Healthcare (DNV. GL) for Continued Approval of its Hospital Accreditation Program

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST

Request for Information: Revisions to Personnel Regulations, Proficiency Testing

THE VALUE OF CAP S Q-PROBES & Q-TRACKS

Standards for Laboratory Accreditation

insights INTO Preparing Your Laboratory For Its Next Survey COLA S FALL 2016 ALSO IN THIS ISSUE: Letter from the Chair... 2

Medical Director Requirements for Nursing Facilities Advance Issuance of Revised Survey Guidance HIGHLIGHTS

Medicare Program; Announcement of the Reapproval of the Joint Commission as an

Laboratory Accreditation Manual

What s New and Improved for the Laboratory Program in 2013 April 23, 2013

Point of Care Testing. BOPCC May 31, 2011 Beatrice O Keefe, Chief Laboratory Field Services California Department of Public Health

8: : : : : : : : : : :

Clinical Laboratory Technologist

Report accurate, timely laboratory results to clinical staff

Primary Ingredients. Primary Ingredients. Referrals. Positive cash-flow. Dedication & growth Give it some time and put effort into it

PART I HAWAII HEALTH SYSTEMS CORPORATION STATE OF HAWAII Class Specification for the

PERSONNEL REQUIREMENTS. March 9, 2018

PURPOSE: This policy provides an overview of SHANDS Jacksonville Laboratory s commitment to the care and safety of the patients we serve.

Medicare Program; Announcement of the Approval of the American Association for

A Different Kind of Exercise

insights COLA Updates Into MAY / JUNE 12 COLA s

Fulton County Medical Center. Position Description. Pathologist, Laboratory Manager, and Medical Technologist

QC Explained Quality Control for Point of Care Testing

Division of Laboratory Systems Protecting America s Health by Strengthening Clinical and Public Health Laboratories

NEW CERTIFICATE PROGRAM PROPOSAL. 1. Title: Clinical Training Certificate Program in Clinical Laboratory Science

College of American Pathologists 325 Waukegan Road, Northfield, Illinois Advancing Excellence

Clinical and Laboratory Standards Institute: Addressing POCT Needs; The Good, The Bad, and The Risky

Plan for Quality to Improve Patient Safety at the POC

The Joint Commission. Survey Activity Guide For Health Care Organizations

SUTTER MEDICAL CENTER, SACRAMENTO DEPARTMENT OF LABORATORY MEDICINE. Rules and Regulations

Point of Care Quality Management. Procedure. Approving Authority: President and CEO, Keith Dewar

THE CALIFORNIA STATE UNIVERSITY Office of the Chancellor 400 Golden Shore Long Beach, CA (562)

The CAP Inspection Process

LABORATORY MEDICINE SERVICE RULES AND REGULATIONS 2016

POSITION DESCRIPTION

CAP Companion Society Meeting at USCAP 2009 Quality Assurance, Error Reduction, and Patient Safety in Anatomic Pathology

TITLE: POINT OF CARE TESTING

1 What is an AAAHC/Medicare Deemed Status survey? 2 What are the Medicare Conditions for Coverage (CfC)?

AMERICAN BOARD OF HISTOCOMPATIBILITY AND IMMUNOGENETICS Laboratory Director. Content Outline


insights Documentation Into COLA s

Laboratory Services Policy, Professional

Symposium for Clinical Laboratories May 30 June 2, 2018: Session Descriptions

Informal Dispute Resolution and Independent Informal Dispute Resolution Key Elements and Updates

Re: Proposed Rule; Medicare Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System FY 2018 (CMS 1677 P)

Job Description. TDL Laboratory Staff, Clients and Customers, Group Blood Transfusion Manager

PROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE

TEXAS DEPARTMENT OF STATE HEALTH SERVICES CLIA APPLICATION

Catholic Health Initiatives

POINT OF CARE TESTING MED Laboratory Branch Kim DeGroat, RMLS - Frankfurt Region Wilfred Lovelock, RMLS - Dakar Region

How to Improve the Laboratory Experience CLS and MLT Working Together

Hospital Crosswalk. Medicare Hospital Requirements to 2012 Joint Commission Hospital Standards & EPs

A COLA White Paper: FEDERAL GOVERNMENT QUESTIONS QUALITY IN WAIVED TESTING.

2016 APHL BIOSAFETY AND BIOSECURITY SURVEY

Master. Point-of-Care-Testing Checklist. CAP Accreditation Program

Surviving Katrina: How Touro Infirmary Met the Challenges of the Disaster! Paula McCreary MT(ASCP) Technical Manager Pathology Department

Potential challenges when assessing organisational processes for assurance of clinical competence in labs with limited clinical staff resource

PRE-DECISIONAL SURVEYOR WORKSHEET. Assessing Hospital Compliance with the. Condition of Participation for Discharge Planning

Master. Point-of-Care-Testing Checklist. CAP Accreditation Program

Allen D. Leman Swine Conference

Transcription:

& Individualized Quality Control Plan (IQCP) Karen W. Dyer MT(ASCP), DLM Director (Acting) Division of Laboratory Services Centers for Medicare & Medicaid Services Disclosure I am not receiving an honorarium for this presentation. 1

Objectives Why are we implementing IQCP? What do laboratories need to do? Is there an Implementation Plan? Why IQCP? Advancements in technology One-size-fits-all no longer fits Based on risk management principles Equivalent Quality Control (EQC) was limited first step 2

EQC vs. IQCP EQC Transitional Standardized Rigid Narrow scope Limited regulations Limited specialties Analytic Requires Internal QC Decreases External QC IQCP Updated Solution Customizable Flexible Broader scope More regulations All but Path Pre Post Analytic Does Not Require Internal QC May or may not decrease QC 6 3

It s Your Choice IQCP is voluntary for laboratories Current control default regulations continue to be in effect Labs have 2 choices: Follow the QC regulations Implement IQCP Will IQCP reduce QC? IQCP is not intended to necessarily reduce QC requirements, but it is intended to ensure effective QC for each laboratory and the tests it performs. 4

IQCP Facts Existing QC & quality system concepts won t change No regulations will change State and local regulations still apply Lab director will continue to have overall responsibility for QCP Laboratory Director Responsibilities The LD is responsible for: Accurate and reliable test results that are appropriate for patient care Ensuring that IQCP meets the requirements as set forth in IQCP Interpretive Guidelines Signing and dating the QCP when implemented and updated. 5

Delegation of Duties by the LD The LD may assign in writing: The responsibility for establishing IQCP as part of the laboratory s overall QC program to the TC/TS Specific portions of IQCP tasks to other qualified laboratory employees Grandfathering of Current Systems No grandfathering for current systems using EQC However, historical data may be used in the development of an IQCP 6

Manufacturer s Instructions Laboratories performing non-waived tests must follow all manufacturers instructions When the manufacturer s instructions for QC are absent or less stringent than the default control procedures the laboratory must choose to develop an IQCP or follow QC regulations Minimum QC Frequency will not set a minimum QC frequency for labs performing IQCP However QC frequency can not be less than the manufacturer s instructions The risk assessment and QC data must support the QC frequency in the lab s Quality Control Plan 7

Specialties/Subspecialties All specialties/subspecialties will be included in IQCP, except... Pathology Histopathology Oral Pathology Cytology How do the regulations relate to IQCP? All regulations remain in force and must be followed Only the eligible regulations identified in the following table(s) may be considered with IQCP Any IQCP eligible regulation that the lab chooses to replace with IQCP must be supported in the RA 8

Table 1: Eligibility for IQCP Specialty/ Subspecialty Eligible for IQCP? General Regulations Eligible for IQCP Specialty/Subspecialty Regulations Eligible for IQCP Specialty/ Subspecialty Regulations NOT Eligible for IQCP Bacteriology Yes 493.1256(d)(3)-(5) Mycobacteriology Yes 493.1256(d)(3)-(5) Mycology Yes 493.1256(d)(3)-(5) Parasitology Yes 493.1256(d)(3)-(5) Virology Yes 493.1256(d)(3)-(5) 493.1261 493.1262 493.1263 493.1264 493.1265 Syphilis Serology Yes 493.1256(d)(3)-(5) General Immunology Yes 493.1256(d)(3)-(5) Table 1: Eligibility for IQCP Specialty/ Subspecialty Eligible for IQCP? General Regulations Eligible for IQCP Specialty/Subspecialty Regulations Eligible for IQCP Specialty/ Subspecialty Regulations NOT Eligible for IQCP Routine Chemistry Yes 493.1256(d)(3)-(5) Urinalysis Yes 493.1256(d)(3)-(5) Endocrinology Yes 493.1256(d)(3)-(5) Toxicology Yes 493.1256(d)(3)-(5) Hematology Yes 493.1256(d)(3)-(5) Immunohematology Yes 493.1256(d)(3)-(5) Clinical Cytogenetics Yes 493.1256(d)(3)-(5) 493.1267(b),(c) 493.1267(a), (d) 493.1269 493.1271 493.1276 9

Table 1: Eligibility for IQCP Specialty/ Subspecialty Eligible for IQCP? General Regulations Eligible for IQCP Specialty/Subspecialty Regulations Eligible for IQCP Specialty/ Subspecialty Regulations NOT Eligible for IQCP Radiobioassay Yes 493.1256(d)(3)-(5) Histocompatibility Yes 493.1256(d)(3)-(5) Pathology No None (Not eligible for IQCP) Histopathology No None (Not eligible for IQCP) Oral Pathology No None (Not eligible for IQCP) Cytology No None (Not eligible for IQCP) 493.1278(b)(6), (c), (d)(6), (e)(3) 493.1278(a), (b)(1-5),(d)(1-5), (d)(7), (e)(1-2), (f),(g) Interpretive Guidelines Individualized Quality Control Plan IQCP RA QCP QA 10

Interpretive Guidelines IQCP - Introduction - Lab Director Responsibilities - Regulatory Considerations - Risk Assessment - Quality Control Plan - Quality Assurance Risk Assessment - Definition The identification and evaluation of potential failures and sources of errors in a testing process (Interpretive Guidelines, Risk Assessment Section) 11

Risk Assessment Risks are potential failures and sources of error that can impact the accuracy and precision of test results Risk assessment is the first step in risk management Identify and evaluate risks in the entire testing process (pre-analytic, analytic, post-analytic) Risk Assessment in IQCP: Components 5 Required Components: Specimen Environment Reagent Test system Testing personnel 12

Risk Assessment in IQCP The risk assessment for any given test system may look very different in different laboratories The same risk may be assigned to different components by different laboratories Risk Assessment in IQCP: Data Requirements Laboratory s own data required Can be new data or historical Data from other sources may be considered, but cannot substitute for a lab s own data 13

Laboratory: Risk Evaluation IQCP does not mandate any specific method of risk evaluation there are many methods a laboratory can use The laboratory must provide documented evidence of the risk assessment Laboratory Risk Evaluation The laboratory director must ensure that the risk assessment considers both the requirements for accurate test results and the responsibility for ensuring that test result quality is adequate for patient care. 14

Linking the RA to QCP After the lab has identified the sources of potential failures and errors for a testing process and evaluated the frequency and impact of those failures and errors, the resulting RA is used to develop the Quality Control Plan (QCP). (Interpretive Guidelines, Risk Assessment Section) Quality Control Plan - Definition A QCP is a document that describes the practices, resources, and procedures to control the quality of a particular test process. (Interpretive Guidelines, Quality Control Plan Section) 15

I Means Individualized Customized/individualized QCP based on lab s specific circumstances (type of testing (subspecialty/specialty), test volume, availability of clinical info, test complexity, patient population & environment. The QCP Must Monitor over time the accuracy and precision of test performance Include the number, type, and frequency of QC Define criteria for acceptability of QC 16

Other information to consider If indicated by the evaluation of the risk assessment, the QCP may also include electronic controls, procedural controls, training and competency assessment, other specified quality control activities Quality Assessment The laboratory must establish a review system for the on-going monitoring of the effectiveness of their QCP. The review system can be part of the laboratory s ongoing Quality Assessment activities 17

Preparing for Implementation of IQCP - Laboratories IQCP Education & Transition (E/T) Period Started Jan.1, 2014 ends Dec. 31, 2015 Learn about IQCP and make transition plans Implement QC choice: IQCP or QC Regulations Three Options for Compliance during E&T period. Follow the regulatory QC requirements as written Continue to follow the EQC procedures as described in the current IGs Implement IQCP as described in S&C-13-54- 18

Timeline for Laboratories Jan.1,2014 Dec.31, 2015: Laboratories may use QC regulations, EQC, or IQCP As of January 1, 2016: Laboratories must follow QC regulations or IQCP. EQC is discontinued. During Educational and Transition (E/T) Period If a laboratory opts to use IQCP. Surveys will be educational for labs implementing IQCP, all other regulations must be met Surveyors are directed to use a Dear Laboratory Director letter" to report any findings for IQCP related issues. 19

Education & Transition Period for IQCP No control procedure regulatory citations will be issued prior to the end of the education & transition period unless serious test quality problems are found If Immediate Jeopardy is identified, deficiencies will be cited End of the Education and Transition Period The Interpretive Guidelines will be revised: EQC will be REMOVED IQCP will be INSERTED 20

After: E/T Period vs Implementation Implementation of IQCP (after Jan. 1, 2016) The lab will have IQCP or default QC regulations All new and existing test systems must be in compliance Accrediting Organizations & IQCP CMS has solicited accrediting organizations (AO) to determine their interest in IQCP Adoption of IQCP requirements in AO/ES programs is voluntary Accredited labs must continue to meet their accreditor s QC standards 21

In summary: IQCP = RA + QCP+ QA Once effective, IQCP will supersede the current EQC policy Existing QC & QS concepts won t change In summary: No regulations will change! Minimally, labs must follow the manufacturer s instructions Lab director has overall responsibility for QCP 22

In summary: Education & transition period for labs before IQCP is fully effective Began: January 1, 2014 Ends: December 31, 2015 Questions? All questions regarding IQCP may be directed to our electronic mailbox IQCP@cms.hhs.gov 23

Where to Obtain Information CMS/ Web site: www.cms.hhs.gov/clia/ 24